OKYO Pharma Insider Trades
NASDAQ: OKYOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 7 · $136.01K
- Sales
- 0 · $0
- Shares bought / sold
- 94.36K / 0
- Net activity
- Net buying $136,006
OKYO Pharma insider activity
Over the last 12 months, OKYO Pharma insiders reported 15 transactions on SEC Form 4: 7 open-market purchases and 0 sales. Insiders bought $136,006 and sold $0 worth of stock, for net insider buying of $136,006. The most recent filing shows Patil Rajkumar V. (Chief Scientific Officer) buying 3,363 shares at $1.49 on Jul 27, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put OKYO's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
OKYO insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 27, 2026 | Patil Rajkumar V.Chief Scientific Officer | Award | 3,363 | $5.01K | Form 4 |
| Jul 27, 2026 | Patil Rajkumar V.Chief Scientific Officer | Buy | 3,363 | $5.01K | Form 4 |
| Jul 22, 2026 | Dempsey Robert JohnCHIEF EXECUTIVE OFFICER | Award | 15,000 | $23.09K | Form 4 |
| Jul 22, 2026 | Dempsey Robert JohnCHIEF EXECUTIVE OFFICER | Buy | 15,000 | $23.09K | Form 4 |
| Jul 21, 2026 | Mantelli FlavioCHIEF MEDICAL OFFICER | Award | 20,000 | $28.00K | Form 4 |
| Jul 21, 2026 | BRANCACCIO JOHN PDirector | Award | 5,000 | $7.38K | Form 4 |
| Jul 21, 2026 | JACOB GARY SCHIEF DEVELOPMENT OFFICER | Award | 3,500 | $4.90K | Form 4 |
| Jul 21, 2026 | CERRONE GABRIELE MDirector | Award | 22,500 | $32.63K | Form 4 |
| Jul 21, 2026 | Mantelli FlavioCHIEF MEDICAL OFFICER | Buy | 20,000 | $28.00K | Form 4 |
| Jul 21, 2026 | CERRONE GABRIELE MDirector | Buy | 22,500 | $32.63K | Form 4 |
| Jul 21, 2026 | JACOB GARY SCHIEF DEVELOPMENT OFFICER | Buy | 3,500 | $4.90K | Form 4 |
| Jul 21, 2026 | BRANCACCIO JOHN PDirector | Buy | 5,000 | $7.38K | Form 4 |
| Jul 20, 2026 | CERRONE GABRIELE MDirector | Award | 25,000 | $35.00K | Form 4 |
| Jul 20, 2026 | CERRONE GABRIELE MDirector | Buy | 25,000 | $35.00K | Form 4 |
| Jun 8, 2026 | CERRONE GABRIELE MDirector | Award | 300,000 | $516.00K | Form 4 |
| Oct 27, 2023 | CERRONE GABRIELE MExecutive Chairman | other | 70,071 | $105.11K | Form 4 |
| Oct 23, 2023 | CERRONE GABRIELE MExecutive Chairman | other | 499,468 | $749.20K | Form 4 |
| Sep 15, 2023 | BRANCACCIO JOHN PDirector | Buy | 16,670 | $25.00K | Form 4 |
| May 19, 2022 | CERRONE GABRIELE MNon-Executive Chairman | Buy | 37,500 | $150.00K | Form 4 |
| May 19, 2022 | JACOB GARY SChief Executive Officer | Buy | 12,500 | $50.00K | Form 4 |
| May 19, 2022 | CERRONE GABRIELE MExecutive Chairman | Buy | 5,800,000 | $440.80K | Form 4 |
| May 17, 2022 | CERRONE GABRIELE MNon-Executive Chairman | Buy | 1,625,000 | $96.69K | Form 4 |
| May 17, 2022 | CERRONE GABRIELE MNon-Executive Chairman | Buy | 25,000 | $96.75K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4